Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|78|1|50-57

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.78, Iss.1, 2007-01, pp. : 50-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Toxicity of 153Samarium-EDTMP in Painful Breast Cancer Bone Metastases

By  

Oncology Research and Treatment, Vol. 32, Iss. 1-2, 2009-01 ,pp. : 35-39

Karger

Access to resources Recommend Favorite

Palliative Treatment of Bone Metastases in Hormone-Refractory Prostate Cancer: Effects of Pamidronate on the Carboxyterminal Telopeptide of Type-I Collagen Level in Patients with Increasing Prostate-Specific Antigen Levels

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 345-350

Karger

Access to resources Recommend Favorite

TREATMENT WITH PREDNISOLONE OF HORMONE-REFRACTORY PROSTATE CANCER

By Fuse H.   Nozaki T.   Fujiuchi Y.   Mizuno I.   Nagakawa O.   Okumura A.  

Archives of Andrology, Vol. 52, Iss. 1, 2006-01 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite

Present Status and Perspectives in the Treatment of Hormone-Refractory Prostate Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 273-282

Karger

Access to resources Recommend Favorite

The Use of the Bone Seeking Radiopharmaceutical 153-Samarium-EDTMP as an Adjuvant Treatment for Osteosarcoma: A Review

By  

Current Medical Imaging Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. : 214-218

Bentham Science Publishers

Access to resources Recommend Favorite